PharmAbcine
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Safety, Tolerability, and Blood Concentration of PMC-309 (NCT05957081) | PharmAbcine | 2024-01-03 |
| Study to Assess Safety and Tolerability of PMC-403 in Subjects With Neovascular Age-related Macular Degeneration (NCT05953012) | PharmAbcine | 2023-07-20 |
| Olinvacimab With Pembrolizumab in Patients With mTNBC (NCT04986852) | PharmAbcine | 2021-09-30 |
| TTAC-0001 Phase II Trial With Recurrent Glioblastoma Progressed on Bevacizumab (NCT03856099) | PharmAbcine | 2019-11-13 |
| TTAC-0001 and Pembrolizumab Combination phase1b Trial in Recurrent Glioblastoma (NCT03722342) | PharmAbcine | 2019-01-16 |
| TTAC-0001 and Pembrolizumab Phase Ib Combination Trial in Metastatic Triple-negative Breast Cancer (NCT03720431) | PharmAbcine | 2019-01-03 |
Track PharmAbcine automatically
Every clearance here is in the API, with alerts when new ones post.